---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-016265"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T03:08:58.625037+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical appoints Todd Usen as CEO; founder Olav Bergheim departs as CEO and Chairman

## Summary
- Olav Bergheim resigns as CEO and Chairman effective Dec 13, 2024; receives severance of $1.2M cash plus contingent $300K.
- Bergheim will serve as advisor for 12 months and receives an option for 338,398 shares of common stock.
- Todd Usen appointed CEO and Director effective Dec 13, 2024; base salary $500K/year, bonus up to 50%, and option for ~5% fully diluted shares.
- Orly Mishan appointed Chairperson of the Board effective Dec 13, 2024.
- Bergheim's departure not due to disagreement with financial reporting or operations.

## SEC filing metadata
- accession: 0001558370-24-016265
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/0001558370-24-016265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/adgm-20241211x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-016265
- JSON: https://secwatch.observer/filing/0001558370-24-016265.json
- Plain text: https://secwatch.observer/filing/0001558370-24-016265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.